Lates News

Every AI Express, Pacific Securities released a research report on August 29th, giving KaiLi Medical (300633.SZ) a buy rating. The main reasons for the rating include: 1) The increase in equipment procurement driving revenue recovery, and performance is about to see a turning point; 2) Research and development investment is yielding results, and the company is experiencing a "big year" for products; 3) Gross profit margin is affected by multiple factors, with continuous increase in investment in research and development and marketing. (Daily Economic News)